<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://vitalspanwire.com/news/epigenetic-clocks-longevity-interventions-translage</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-21T16:02:20.087Z</news:publication_date><news:title>Large human-study analysis tests which epigenetic clocks respond to longevity interventions</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/bmal1-yap-aged-skin-inflammation-mice</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-21T11:01:58.514Z</news:publication_date><news:title>Aging redirects two skin regulators toward inflammatory genes in mice</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/fda-glp1-api-import-alert-orforglipron</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-20T21:02:59.049Z</news:publication_date><news:title>FDA updates border controls for GLP-1 drug ingredients</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/brain-stimulation-postoperative-delirium-older-adults</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-20T16:02:35.390Z</news:publication_date><news:title>Brain stimulation did not prevent postoperative delirium in older adults</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/cytotoxic-cd4-t-cells-centenarians-longevity</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-20T11:02:23.337Z</news:publication_date><news:title>Rare cytotoxic T cells expand in centenarians, but their role in longevity remains unclear</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/intismeran-keytruda-phase-3-melanoma-endpoints</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-19T21:02:24.444Z</news:publication_date><news:title>Intismeran combination meets Phase 3 melanoma endpoints, but effect size remains undisclosed</news:title></news:news></url></urlset>